• OBJECTIVE DROWSINESS. SOLVED.

    Optalert presents at InCabin Conference, Brussels

  • MAXIMISING YOUR NCAP 2023 RATING

    Optalert Automotive

  • THE NEXT THRESHOLD: DRIVER INCAPACITY

    Optalert MOVES BEYOND DROWSINESS

  • Alert & Alive

    Optalert Mining & transport

AUTOMOTIVE

Optalert enables simple and fast Euro NCAP & GSR compliance.

MINING & TRANSPORT

Optalert reduces the risk of accidents at mining sites and maximises productivity.

DRIVER INCAPACITY

Identifying breakthrough biomarkers for neurological conditions at the wheel.

Renowned as experts in drowsiness/wakefulness detection, Optalert is now exploring new pathways in the automotive industry, pharmaceutical drug trials and neurological research. Sign up today to keep up to date with the latest news from Optalert.

Dr Murray John’s latest publication – Now available

The Assessment of ‘Sleepiness’ in Human Drug Trials: A New Perspective
Current Psychopharmacology 2019, Volume 8, Issue 1

OPTALERT’S EARLY-WARNING SYSTEM IS TRUSTED BY MAJOR GLOBAL BLUE CHIP COMPANIES